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An Inverted Repeat in the ospC Operator Is Required for
Induction in Borrelia burgdorferi
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Abstract
Borrelia burgdorferi, the spirochete that causes Lyme disease, differentially regulates synthesis of the outer membrane
lipoprotein OspC to infect its host. OspC is required to establish infection but then repressed in the mammal to avoid
clearance by the adaptive immune response. Inverted repeats (IR) upstream of the promoter have been implicated as an
operator to regulate ospC expression. We molecularly dissected the distal inverted repeat (dIR) of the ospC operator by sitedirected mutagenesis at its endogenous location on the circular plasmid cp26. We found that disrupting the dIR but
maintaining the proximal IR prevented induction of OspC synthesis by DNA supercoiling, temperature, and pH. Moreover,
the base-pairing potential of the two halves of the dIR was more important than the nucleotide sequence in controlling
OspC levels. These results describe a cis-acting element essential for the expression of the virulence factor OspC.
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and facilitating dissemination [27]. Additionally, OspC has a
ligand-binding domain essential for its function [28] and binds the
tick salivary protein Salp15 [29] as well as mammalian plasminogen [30,31], which may assist in transmission and dissemination,
respectively. OspC is highly immunogenic, so its synthesis must be
repressed for the spirochete to persist in the mammal [32–34]. B.
burgdorferi that continue to produce OspC during infection of
immunocompetent mice are cleared [34] and ospC expressed in
trans from a shuttle vector is selected against during mammalian
infection [35]. While ospC is present in all B. burgdorferi strains
examined, the sequence is variable, with only strains carrying
certain alleles capable of disseminating and establishing infection
in humans [13,36–39].
OspC synthesis is induced in vitro in response to increased
temperature, which presumably mimics a signal that occurs during
tick feeding [40–42]. Subsequent studies showed that numerous
factors such as pH [43,44], DNA supercoiling [42], oxygen [45],
carbon dioxide [46], acetate [47], and transition metals [48] also
control ospC expression. External signals are transmitted through a
unique signaling pathway involving the sequential action of two
alternative sigma factors, RpoN (s54) and RpoS (ss) [49,50].
RpoN, in collaboration with the response regulator Rrp2 [51–54]
and the transcription factor BosR [55–58], activates transcription
of rpoS; RpoS, in turn, activates transcription of ospC [49] and
other genes [54,59,60]. Another level of control of ospC expression
is exerted during translation of rpoS. The small RNA DsrABb
[61,62] and the RNA chaperone Hfq [63] control rpoS translation

Introduction
Lyme disease is caused by the spirochete Borrelia burgdorferi,
which is transmitted via an Ixodes tick [1–3]. B. burgdorferi is
maintained in an enzootic cycle between its tick vector and a
vertebrate host reservoir [4–6]. Naı̈ve larvae acquire B. burgdorferi
when feeding on an infected animal and can then transmit the
bacterium to uninfected hosts as nymphs during feeding,
completing the cycle. B. burgdorferi encounters disparate, and
hostile, environments as it transitions through the enzootic cycle;
the spirochete has evolved a repertoire of strategies, which involve
the regulation of a variety of genes, to respond and adapt to these
changes during its lifecycle [6–8].
The differential syntheses of outer surface lipoproteins (Osp),
which are the interface between B. burgdorferi and its hosts, is
paramount to the ability to infect, survive and replicate in both the
tick and the vertebrate [6–10]. These regulated genes encode
wide-ranging functions; for example, VlsE mediates evasion from
the vertebrate immune system [11–13], while OspA binds to a tick
midgut protein and protects the spirochetes from the incoming
blood meal [14–17]. One of the best-studied lipoproteins is OspC
[18], which is required for transmission and the early stages of
mammalian infection [19–22]. The ospC gene is carried on the
conserved 26-kb circular plasmid cp26 [23,24]. The precise
function of OspC remains elusive, but the outer membrane
lipoprotein appears to have several activities [25], including
providing initial protection from the innate immune system [26]
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construct, which was cloned into pCRH2.1-TOPO as described
above. The accuracy of all DNA constructs was confirmed by
sequencing. The downstream sequence was inserted into the
upstream ospC operator mutation constructs using the synthetic
AatII and AgeI restriction sites. Lastly, the kanamycin resistance
cassette flgBp-aphI [74] was inserted downstream of the ospC gene
into the engineered AatII site. The orientation of flgBp-aphI was
determined by PCR using the primers kanR 488R and ospC
D1572R+AgeI (primers a and b, respectively). The plasmid was
linearized by digestion with AhdI and electroporated into
competent B. burgdorferi [61,71,72]. Transformants were cloned
in liquid BSK-II by diluting the electroporated cells to less than
one cell per well of a 96-well plate in medium containing
kanamycin (200 mg ml21) at 34uC and a 1.5% CO2 atmosphere
[16]. Total genomic DNA was isolated from positive colonies and
sequenced by the Murdock DNA Sequencing Facility at The
University of Montana using the primer ospC U291F to confirm
the site-directed ospC operator mutations.

and subsequently ospC transcription. However, there is no
evidence for post-transcriptional control of the ospC gene [42,44–
49,52,61,64].
Previous studies identified an ospC operator consisting of two
overlapping inverted repeats (IRs) 42 bp upstream of the major
transcriptional start site [23,65–67]. The operator is highly
conserved in B. burgdorferi sensu stricto [67], but there is some
controversy about its role in ospC gene regulation. Eggers et al.
[64] showed that the operator is required for full ospC expression
in vitro, while Yang et al. [68] found the operator is dispensable for
induction and repression. In addition, mutants lacking the
operator were unable to persist in immunocompetent mice and
were also cleared from SCID mice injected with transferred antiOspC antibodies, suggesting that the operator is required to
repress ospC expression during infection [69]. One caveat to these
previous studies is that ospC was expressed in trans in an ospC null
background strain. In the current study, we molecularly dissect the
ospC operator in its native locus on cp26 and show that the distal
IR is an important cis-acting element controlling OspC expression.

RNA Isolation and qRT-PCR Analysis
Materials and Methods

RNA was isolated from 40-ml cultures of B. burgdorferi grown at
23uC containing 10 ng ml21 coumermycin A1 or DMSO as a
solvent control using TRIzol (Invitrogen) as previously described
[61,75]. Samples were treated with Turbo DNase (Ambion) to
remove contaminating DNA. Samples were screened by PCR to
ensure that contaminating DNA had been removed using the
primers flaB 423F and flaB 542R. cDNA was synthesized using
1 mg RNA with SuperScriptH III for qRT-PCR (Invitrogen). flaB
and ospC primers and probes were designed using Primer ExpressH
version 3.0 (Applied Biosystems). TaqMan absolute qRT-PCR
was performed in 96-well plates using an Applied Biosystems 7300
Real-Time PCR System and standard curves for flaB and ospC
were generated using a portion of the flaB ORF (nucleotides 278–
551 of the ORF) cloned into pCRH2.1-TOPO and B. burgdorferi
strain 297 (BbAH130) genomic DNA, respectively. Values
represent the mean (6SE) from three independent experiments.

Bacterial Strains and Culture Conditions
Low-passage B. burgdorferi strain 297 (BbAH130) [49] and all
mutant strains were maintained in Barbour-Stoenner-Kelly II
(BSK-II) liquid medium, pH 7.6, containing 6% rabbit serum
[70]. In temperature shift experiments, cultures were passaged
twice at 23uC, before inoculating cultures at 16105 cells ml21 and
growing at 23uC to late log phase (5 to 96107 cells ml21) or
inoculating cultures at 16103 cells ml21 and growing at 34uC to
late log phase. For temperature downshift experiments, cultures
were grown to log phase at 34uC before inoculating cultures at
16105 cells ml21 and growing at 23uC to late log phase. In
experiments examining the effect of pH, cultures at 34uC in BSK
II at pH 8.0 were passaged into BSK II at pH 7.0. To determine
the effect of DNA supercoiling, cultures were grown at 23uC
(inoculated at 16105 cells ml21) in the presence of 10 ng ml21
coumermycin A1 (50 mg ml21 stock in DMSO) or DMSO (solvent
control) until late log phase [42]. Cell density was determined
using a Petroff-Hausser counting chamber [71].

SDS-PAGE and Immunoblotting
B. burgdorferi cultures were grown to late log phase at 23uC or
34uC and total cell lysates collected as previously described
[61,72]. Equal amounts of protein were separated on pre-cast
Novex 4–20% Tris-Glycine polyacrylamide gels (Invitrogen).
Proteins were transferred by electroblotting to PVDF ImmobilonTM membranes (Millipore) and membranes blocked in Blocking
Buffer (138 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4,
1.5 mM KH2PO4, 0.05% Tween 20, 4% dry milk, and 1% goat
serum) overnight at 4uC. Membranes were incubated with rabbit
anti-OspC antibodies (1:1000) [68,76] or anti-FlaB antibodies
(1:1000) (a kind gift from Tom Schwan) in Blocking Buffer for 1 h
at room temperature. Rabbit antibodies were detected by
incubating membranes with goat anti-rabbit HRP-linked antibodies (Bio-Rad Laboratories) (1:20,000) in Blocking Buffer for 1 h at
room temperature. HRP-linked antibodies were visualized by
chemiluminescence using AmershamTM ECL Plus (GE Healthcare) and images were collected using an LAS-3000 Intelligent
Dark Box (Fujifilm Medical Systems USA). Images were processed
using ImageJ (US National Institutes of Health and available at
http://rsbweb.nih.gov/ij/) and Pixelmator (Pixelmator Team,
Ltd).

Construction of ospC Promoter Mutants
Mutations in the ospC operator were generated by allelic
exchange on cp26 [72]. Constructs containing the operator
mutants were made by overlap extension PCR [73]. The 59
portion of the upstream construct was amplified by PCR of
genomic DNA using KOD polymerase (Novagen) with the
primers ospC U866F and ospCp mutHup(297)R or ospCp
mutDH(297)R2 (Table 1). The 39 portion of the upstream
construct, which also includes the ospC gene, was amplified by
PCR using the primers ospC D697R+AatII+AgeI and ospCp
mutHup(297)F (Table 1). PCR products were separated and
purified in a 1% agarose gel. Paired 59 and 39 portions of the
upstream construct were then combined and extended for six
cycles in a thermal cycler. Next, the primers ospC U866F and
ospC D697R+AatII+AgeI (Table 1) were added and the combined
upstream construct was amplified by PCR. To generate the
construct for the wild-type control strain with the antibiotic
resistance cassette, PCR was done using primers ospC U866F and
ospC D697R+AatII+AgeI with genomic DNA as a template. PCR
products were separated in a 1% agarose gel, gel purified,
polyadenylated, and cloned into pCRH2.1-TOPO. PCR of
genomic DNA with the primers ospC D673F+AatII and ospC
D1572R+AgeI (Table 1) was used to amplify the downstream
PLOS ONE | www.plosone.org
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Table 1. Oligonucleotides used in this studya.

Name

Sequence (59-39)

ospC U866F

AGCTTAATTTTTTCCACAATGG

ospC D697R+AatII+AgeI

ACCGGTAATGACGTCTGACTTATATTGACTTTATTTTTCCAG

ospC D673F+AatII

GACGTCGGAAAAATAAAGTCAATATAAGTCAAG

ospC D1572R+AgeI

ACCGGTAATGGAAAAATTCCTAATGTCG

ospC U291F

ATTAGTTGGCTATATTGGG

kanR 488R

TCACTCGCATCAACCAAACC

ospCp mutHup(297)F

TAAGACAATATTGAAAAAATTCTTCAAT

ospCp mutHup(297)R

ATTGAAGAATTTTTTCAATATTGTCTTA

ospCp mutDH(297)R2

TTTCAATTTTTTATTTTTTCAAATATTTGAAAAAATTCTTCAATATTT

flaB 423F

TTCTCAAAATGTAAGAACAGCTGAAGA

flaB 542R

TGGTTTGTCCAACATGAACTC

flaB probe

6-FAM-TCACTTTCAGGGTCTCAAGCGTCTTGGAC-TAMRA

ospC F

CATGGGCAACTTGGAATTGA

ospC R

TTGCCAAGTTTTCTACTGCTTTAAATAG

ospC probe

6-FAM-TAAAGATAAGGGCGCTGCAGAGC-TAMRA

a
Synthetic restriction sites are underlined.
doi:10.1371/journal.pone.0068799.t001

of the operator. Transcript levels of ospC and flaB were measured
by qRT-PCR. The fold increase in ospC transcript in the dIR+
strain grown in coumermycin A1, compared to the solvent control,
was significantly greater than that seen in the dIR2 strain (about
thirteenfold compared to less than twofold) (Fig. 3). The change in
flaB transcript levels was about twofold or less for both the dIR+
and dIR2 strains (Fig. 3). These data suggest that the ability to
form the dIR is an important regulator of coumermycin A1mediated ospC expression.
To examine if the changes in ospC transcript levels in response to
coumermycin A1 treatment were reflected in OspC protein levels,
total cell lysates were analyzed by Western blot using polyclonal
antibodies to OspC to determine the levels of OspC synthesis.
OspC levels increased in the wild-type 297 strain in response to
relaxation of supercoiling when grown at 23uC in the presence of
coumermycin A1 compared to cultures grown in the DMSO
control (Fig. 4). Very little OspC was produced when the dIR2
strain was grown in coumermycin A1 compared with the wild-type
strain and the dIR+ strain (Fig. 4). We have confirmed these results
with a second independently constructed clone of each of the
mutant strains (data not shown). Taken together, these results
suggest that the ability to form the dIR is more important than the
actual sequence, at least in regard to the nucleotides that we
mutated. These data imply that the increase in OspC levels
stimulated by relaxation of DNA supercoiling is mediated via the

strains (Fig. 1) [65–67]. We hypothesized that the dIR has a
specific role in responding to changes in DNA supercoiling, which
is known to regulate ospC expression [42]. Increased negative DNA
supercoiling can alter DNA structure, including extrusion of
cruciforms from IRs, which can have a regulatory effect on
transcription [77–79]. We generated site-directed mutations in the
native ospC operator on cp26 that specifically disrupted the dIR
(dIR–) and that changed the dIR sequence but retained
complementarity (dIR+) (Fig. 2A; sequence changes are in bold).
The orientation of the kanamycin resistance cassette, flgBp-aphI,
downstream of the ospC gene was determined by PCR using the
primer sets a+b (Fig. 2B). Changes in the operator sequence of the
mutant strains were confirmed by DNA sequencing; about onethird of the kanamycin-resistant clones contained the site-directed
mutations.

The Role of the dIR in ospC Expression Induced by
Relaxation of DNA Supercoiling
We have previously shown that a decrease in negative DNA
supercoiling causes an increase in ospC transcription [42]. The
antibiotic coumermycin A1 relaxes DNA supercoiling by inhibiting
DNA gyrase [80–83]. Wild-type and mutant strains were grown at
23uC in the presence of coumermycin A1 or DMSO (solvent only
control) until late log phase to examine if the increase in ospC
expression by the relaxation of supercoiling is mediated by the dIR

Figure 1. The sequence of the B. burgdorferi strain 297 ospC operator. Two overlapping inverted repeats (IR): proximal (pIR, dashed arrows)
and distal (dIR, solid arrows) of the ospC operator. The promoter (210 and 235) and ribosome-binding site (RBS) are in bold and the translational
start site is in italics.
doi:10.1371/journal.pone.0068799.g001
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Figure 2. The ospC operator and mutagenesis strategy. (A) ospC operator mutations are linked to the kanamycin resistance cassette (flgBpaphI). The sequence upstream of the ospC gene in B. burgdorferi strain 297 is shown (WT) with the dIR (solid arrows) and the overlapping pIR (dashed
arrows). The nucleotides that have been changed are marked in bold. The strain nomenclature is as follows: dIR+ has the nucleotide sequence
changed but the complementarity of the inverted repeats maintained, and dIR2 has the distal inverted repeat disrupted but the complementarity of
the proximal IR intact. (B) PCR of genomic DNA from ospC operator mutants (lane 1, WT with flgBp-aphI cassette; lane 2, dIR+; lane 3, dIR2; and lane 4,
no template control) using primers primers kanR 488R (a) and ospC D1572R+AgeI (b) to determine the orientation of the flgBp-aphI antibiotic
resistance cassette.
doi:10.1371/journal.pone.0068799.g002

dIR of the operator and that the secondary structure of the
operator, rather than its sequence, plays a dominant role in
regulating OspC levels.

The Role of the dIR in Temperature-regulated OspC
Synthesis
A temperature shift from 23uC to 34uC is commonly used
in vitro to mimic an environmental signal during tick feeding that
induces virulence gene expression [8,40]. To assess the role of the
dIR in temperature-regulated OspC expression, cultures were
grown at 23uC, shifted to 34uC and grown to late log phase. Total
cell extracts were analyzed by Western blot. The wild-type 297
strain increased OspC synthesis upon a temperature shift (Fig. 5A).
Similar to the coumermycin A1 treatment, OspC was not induced
in response to temperature shift when the dIR was disrupted, while
regenerating the complementarity of the dIR restored the ability to
respond to increased temperature with increased OspC levels in
the dIR+ strain (Fig. 5A). A second clone of each mutant, from an
independent transformation, showed the same pattern of OspC
levels during temperature shift (data not shown).
We next assayed if the dIR was also involved in reducing OspC
levels at 23uC. Cultures were grown to late log phase at 34uC and
then passaged and grown at 23uC to late log phase. Again,
changing the dIR sequence but maintaining complementarity in
the dIR+ strain allowed for the reduction in OspC levels similar to
the wild-type strain shifted to 23uC (Fig. 5B).

Figure 3. ospC expression induced by relaxation of supercoiling is dependent on the dIR of the operator. qRT-PCR analyses of
flaB (gray bars) and ospC (black bars) mRNA levels from strains grown to
late log phase at 23uC in 10 ng ml21 coumermycin A1 (Cou) or in DMSO
as a solvent control. Values represent the mean and error bars the SE of
the mean from three independent experiments. * = P,0.05 by an
unpaired t-test.
doi:10.1371/journal.pone.0068799.g003
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The Role of the dIR in pH-regulated OspC Synthesis
OspC levels have also been shown to be regulated by pH
[43,44], which is considered an environmental signal that changes
during tick feeding: reducing the pH to 7.0 increases and raising
the pH to 8.0 decreases OspC levels. To examine if pH-regulated
OspC expression is mediated through the dIR, cultures were
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Figure 4. The role of the dIR in OspC synthesis mediated by
relaxation of DNA supercoiling. Immunoblot analysis of whole-cell
lysates from strains grown to late log phase at 23uC in 10 ng ml21
coumermycin A1 (Cou) (+) or in DMSO as a solvent control (2).
Membranes were probed with antibodies against OspC (upper panel) or
FlaB (lower panel).
doi:10.1371/journal.pone.0068799.g004

grown at 34uC in medium at pH 7.0 and then passaged into
medium at pH 8.0. Total cell extracts were collected at late log
phase and OspC levels were analyzed by Western blot. The dIR–
strain did not show increased OspC levels at pH 7.0 and the dIR+
strain behaved like the wild-type strain in response to changing the
pH (Fig. 6). Thus, all the signals examined, DNA supercoiling,
temperature, and pH, control OspC levels through the dIR of the
operator in vitro, suggesting a common mechanism, and the
complementarity of the dIR may be more important than the
specific sequence.

Figure 5. The dIR is required for OspC synthesis regulated by
temperature. (A) Immunoblot analysis of whole-cell lysates from
strains grown at 23uC and then temperature shifted to 34uC and grown
to late log phase. The wild-type parental strain (297 WT) and the strain
with a wild-type ospC operator linked to the antibiotic resistance
cassette (WT) are controls. (B) Immunoblot analysis of whole-cell lysates
from strains grown at 34uC and then temperature shifted to 23uC and
grown to late log phase. Membranes were probed with antibodies
against OspC (upper panels) or FlaB (lower panels).
doi:10.1371/journal.pone.0068799.g005

Discussion
Induction and repression of ospC transcription are crucial for B.
burgdorferi to establish and maintain, respectively, an infection in
mammals. A number of external factors, including temperature,
pH, oxygen, carbon dioxide, acetate, and transition metals,
regulate ospC expression [40–48,72,84]. Induction of ospC expression is generally accepted to be dependent on the RpoN-RpoS
sigma factor cascade [49], which includes the regulatory proteins
Rrp2 [51–54] and BosR [55–58]. Considerably less is known
concerning the repression of ospC transcription, including the
signals and accessory proteins involved. Here we show that the cisacting dIR of the ospC operator functions to control expression and
our data indicate that the base-pairing potential of the two halves
of the inverted repeat, rather than the specific sequence, is
essential for induction, thus providing a level of ospC-specific
regulation downstream of RpoS.
The large intergenic region upstream of the ospC gene contains
the operator and is highly conserved among B. burgdorferi sensu
stricto strains, much more so than the ospC gene itself, likely
indicating selective pressure on the regulation of ospC expression
[65,67]. Certain features of the operator, including the proximal
IR (pIR), are broadly conserved throughout B. burgdorferi sensu lato
genospecies, but, inexplicably, the dIR does not overlap the pIR in
B. afzelii strains and is not even obviously present in B. garinii
strains [67], suggesting alternate modes of gene regulation.
Although we and others previously had shown that deleting the
operator has little effect on the regulation of ospC transcription
[68,69], our current results more closely agree with Eggers et al.
[64], who showed that the entire operator was required for full
ospC expression in response to a temperature shift. These data
suggest that the dIR plays a role in ospC regulation. This
discrepancy may be explained by the differences in the experimental approaches between the studies. In the present work, we
have utilized a more precise method to dissect the operator: sitePLOS ONE | www.plosone.org

directed mutations were generated in cis in the endogenous

Figure 6. The role of the dIR in OspC synthesis mediated by pH
increase. Immunoblot analysis of whole-cell lysates from strains grown
to late log phase at 34uC at pH 7.0 or shifted to pH 8.0. Membranes
were analyzed by probing with antibodies against OspC (upper panel)
or FlaB (lower panel).
doi:10.1371/journal.pone.0068799.g006

operator on cp26, while the other studies utilized truncated
operator mutants in trans on a shuttle vector in an ospC null
background. Thus, ospC expression in trans from a plasmid much
smaller than cp26 (7 kb compared to 26 kb), albeit still circular,
with a strong promoter fused to a selectable marker, may affect
operator function, especially when DNA topology is likely involved
[42,68,85]. In fact, OspC levels expressed in trans were elevated at
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23uC compared to wild type, even though the plasmid-borne ospC
contained the entire operator region [68].
Mutations that disrupt the dIR, but maintain the pIR (dIR2
strain) prevent an increase in OspC levels in response to
temperature, pH or relaxation of supercoiling, suggesting that all
these signals function through a similar mechanism. Thus, the dIR
is required for an increase in the amount of OspC. The finding
that the ospC induction by relaxation of supercoiling at 23uC with
coumermycin A1 (Fig. 3) depends on the dIR suggests that DNA
topology has a regulatory role. These data imply that the
regulatory element may be the DNA structure rather than the
sequence, although we may not have mutated the nucleotides in
the dIR+ strain that are important in regulation. We propose that
the inverted repeats mediate the effect of DNA supercoiling,
possibly by extruding a cruciform, or bind a trans-acting factor that
recognizes an alternative DNA secondary structure. This provides
a molecular mechanism for our previous observation that
relaxation of supercoiling induces ospC expression [42].
Finally, we are aware of only a handful of studies in which sitedirected mutations were introduced in cis into the genome of B.

burgdorferi [51,73,86,87] and this work provides an important
caveat for interpreting genetic experiments involving introduction
of DNA in trans, albeit the methodology is considerably more
convenient. Our results add another level of complexity to ospC
regulation suggesting that the DNA structure of the operator
serves to mediate the external signals affecting expression.
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